Back to funds
View filing
SPHERA FUNDS MANAGEMENT LTD.
hedge fundUpdated 27 days agoManaged by Sphera Funds Management Ltd. • Latest filing Q2 2026
Portfolio value
$766.5M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
91.2%
Weight of largest holdings
Annualized return
2.1%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $598.4M |
| Q2 2023 | $640.4M |
| Q3 2023 | $549M |
| Q4 2023 | $621.3M |
| Q1 2024 | $711.7M |
| Q2 2024 | $733.2M |
| Q3 2024 | $628.4M |
| Q4 2024 | $553.1M |
| Q1 2025 | $434.3M |
| Q2 2025 | $426.1M |
| Q3 2025 | $474.1M |
| Q4 2025 | $517.3M |
| Q1 2026 | $629.7M |
| Q2 2026 | $766.5M |
Top holdings
106 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TEVJF TEVA PHARMACEUTICAL INDS LTD | $47.8M | 1.41M | 6.23% | — |
| 2 | M MLYS MINERALYS THERAPEUTICS INC | $39.7M | 1.47M | 5.17% | — |
| 3 | T TSEM TOWER SEMICONDUCTOR LTD | $28.2M | 108.3K | 3.68% | — |
| 4 | S STT-PG SPDR SERIES TRUST | $23.7M | 150.0K | 3.10% | — |
| 5 | S SNDX SYNDAX PHARMACEUTICALS INC | $22.2M | 1.01M | 2.89% | — |
| 6 | B BIIB BIOGEN INC | $21.6M | 100.0K | 2.82% | — |
| 7 | B BIIB BIOGEN INC | $20.9M | 96.6K | 2.72% | — |
| 8 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $19.6M | 588.5K | 2.56% | — |
| 9 | B BMRN BIOMARIN PHARMACEUTICAL INC | $18.8M | 328.6K | 2.45% | — |
| 10 | C CYTK CYTOKINETICS INC | $18.7M | 220.0K | 2.44% | — |
| 11 | B BBIO BRIDGEBIO PHARMA INC | $18.3M | 245.3K | 2.38% | — |
| 12 | C COGT COGENT BIOSCIENCES INC | $17.8M | 459.3K | 2.32% | — |
| 13 | A ASMLF NOVA LTD | $13.7M | 25.2K | 1.78% | — |
| 14 | I INSM INSMED INC | $12.7M | 118.8K | 1.65% | — |
| 15 | M MAZE MAZE THERAPEUTICS INC | $12.5M | 417.6K | 1.63% | — |
| 16 | A AZN ASTRAZENECA PLC | $11.9M | 62.5K | 1.55% | — |
| 17 | S SNYNF SANOFI SA | $11.5M | 269.5K | 1.50% | — |
| 18 | H HELP CYBIN INC | $10.7M | 1.62M | 1.40% | — |
| 19 | L LLY ELI LILLY & CO | $9.6M | 8.0K | 1.26% | — |
| 20 | M MDGL MADRIGAL PHARMACEUTICALS INC | $9.4M | 17.4K | 1.22% | — |